Related Experiment Videos
State of the art: bronchiolitis
The American Review of Respiratory Disease
|October 1, 1978
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Relationship between insulin-like growth factor I, dehydroepiandrosterone sulfate and proresorptive cytokines and bone density in cystic fibrosis.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2006
Bronchopulmonary dysplasia (chronic lung disease of infancy): an update for the pediatrician.
Clinical pediatrics·2002
Functional antibody activity elicited by fractional doses of Haemophilus influenzae type b conjugate vaccine (polyribosylribitol phosphate-tetanus toxoid conjugate).
Clinical and diagnostic laboratory immunology·2001
Respiratory diseases in the first year of life in children born to HIV-1-infected women.
Pediatric pulmonology·2001
Forced expiratory flow in uninfected infants and children born to HIV-infected mothers.
American journal of respiratory and critical care medicine·2001
Human lung lysozyme: sources and properties.
The American review of respiratory disease·2015
Cell adhesion molecules and the bronchial epithelium.
The American review of respiratory disease·1993
Adhesion molecules and cytokine production.
The American review of respiratory disease·1993
Molecular mechanisms mediating lymphocyte recirculation, inflammation, and metastasis formation.
The American review of respiratory disease·1993
Mechanisms of neutrophil and eosinophil accumulation in vivo.
The American review of respiratory disease·1993
Identification and characterization of novel airway epithelial integrins.
The American review of respiratory disease·1993
Upadacitinib for refractory generalized lichen sclerosus: a case report and brief literature review.
Frontiers in immunology·2026
Case Report: A case report of bullous pemphigoid triggered by sintilimab (PD-1 inhibitor).
Frontiers in immunology·2026